Table 2 Type and stage of cancer in the 418 oncogeriatric patients evaluated at the Geriatric Frailty Clinic
From: Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology
| Characteristics | N (%) |
|---|---|
| Type of cancers (solid cancers) | 339 (81.1) |
| Digestive cancer | 124 (29.7) |
| Colorectal | 86 (69.3) |
| Stomach | 10 (8.1) |
| Pancreas cancer | 11 (8.9) |
| Other (esophageal, hepatic, duodenal, cholangiocarcinoma …) | 17 (13.7) |
| Urologic cancer | 77 (18.4) |
| Bladder | 41 (53.2) |
| Kidney | 26 (33.8) |
| Prostate | 10 (13.0) |
| Gynecologic cancer | 70 (16.8) |
| Breast | 52 (74.3) |
| Ovarian | 9 (12.9) |
| Other | 9 (12.9) |
| Head and neck Cancer | 24 (5.7) |
| Lung cancer | 18 (4.3) |
| Skin cancer | 10 (2.4) |
| Melanoma | 3 (0.30%) |
| Non-melanoma | 7 (0.70%) |
| Other | 16 (3.8) |
| Cancer stage | |
| Local | 155 (37.1) |
| Loco-regional | 75 (17.9) |
| Metastasis | 109 (26.1) |
| Hematological cancer | 79 (18.9) |
| Lymphoma | 23 (29.1) |
| Acute myelogenous leukemia | 1 (1.3) |
| Myelodysplastic syndrome | 8 (10.1) |
| Multiple myeloma | 13 (16.5) |
| Chronic lymphocytic leukemia | 34 (43.0) |